Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 6/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 6/20 | 0.42 |
| ▸ | CYP11B2 | P19099 | 6/20 | 0.42 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.42 |
| ▸ | ERN1 | O75460 | 1/20 | 0.39 |
| ▸ | METAP2 | P50579 | 1/20 | 0.38 |
| ▸ | DHODH | Q02127 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9973717 | 0.89 | METAP2 (0.45) | CYP19A1CYP11B1CYP11B2CYP17A1METAP2 | |
| SCHEMBL16560616 | 0.87 | CYP11B2 (0.51) | CYP19A1CYP11B1CYP11B2CYP17A1 | |
| SCHEMBL24344945 | 0.86 | KDM4E (0.39) | METAP2DHODHKDM4EATML3MBTL1 | |
| SCHEMBL9973757 | 0.85 | CYP19A1 (0.43) | CYP19A1CYP11B1CYP11B2CYP17A1METAP2 | |
| SCHEMBL9973767 | 0.84 | CYP2A6 (0.45) | CYP19A1METAP2CYP2A6 | |
| SCHEMBL12554398 | 0.82 | CYP11B1 (0.39) | CYP11B1METAP2DHODHCYP2A6MAPT | |
| SCHEMBL9973737 | 0.82 | CYP2A6 (0.44) | CYP19A1CYP11B1CYP11B2CYP17A1DHODH | |
| SCHEMBL9973728 | 0.82 | CYP2A6 (0.44) | CYP19A1CYP11B1CYP11B2CYP17A1DHODH | |
| SCHEMBL9973716 | 0.82 | CYP11B2 (0.53) | CYP19A1CYP11B1CYP11B2CYP17A1ERN1 | |
| SCHEMBL21190466 | 0.81 | L3MBTL1 (0.56) | MAPTKDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230145851-A1 | INTERFACE LAYER DESIGN FOR EFFICIENT AND STABLE WHITE OLEDS | UNITED STATES DEPARTMENT OF ENERGY | 2023-05-11 | — | — | US | disclosed |
| US-20230145851-A1 | INTERFACE LAYER DESIGN FOR EFFICIENT AND STABLE WHITE OLEDS | UNITED STATES DEPARTMENT OF ENERGY | 2023-05-11 | — | — | US | disclosed |
| US-20220102641-A1 | FUNCTIONAL MATERIALS FOR OLED APPLICATIONS | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2022-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220102641-A1 | FUNCTIONAL MATERIALS FOR OLED APPLICATIONS | OCIAD1, OGFOD1, SLCO1A2 | CYP19A1 103/4885CYP11B1 176/4885CYP11B2 252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.